The brave 13-year-old girl helped to inspire the global movement to legalize CBD, improving the lives of millions of people throughout the world.
The COVID-19 pandemic took another tragic turn today, after it claimed the life of 13-year-old Colorado Springs girl, Charlotte Figi, who's inspiring fight against epilepsy helped launch a movement that led to the legalization of medicinal marijuana around the globe.
Charlotte's family confirmed her death on Tuesday night via the Facebook page of her mother, Paige Figi, which stated that, "her fighting spirit held out as long as it could and she eventually passed in our arms peacefully."
"Charlotte is no longer suffering. She is seizure-free forever. Thank you so much for all of your love," the post read.
However, while she was treated as a "likely COVID-19 case", public health officials have yet to confirm whether her death was directly to the coronavirus, despite "using all of the medical protocols set in place" for treating the disease.
Your work is done Charlotte, the world is changed, and you can now rest knowing that you leave the world a better place. The Realm of Caring Foundation
Charlotte suffered from Dravet Syndrome—a rare and difficult to treat form of epilepsy that typically appears in childhood—which was causing her to experience hundreds of seizures per day by the time she was three months old.
Unfortunately, pharmaceutical treatment proved ineffective for Charlotte, and by the time she was five she was struggling to walk and talk.
Things seemed desperate until a lifeline appeared in the form of an unnamed Californian family that had supposedly managed to treat their child's epilepsy using cannabis oil.
The Figi's heard about the child's miraculous recovery, which prompted them to approach a Colorado Springs dispensary owner, Joel Stanley, who would team up with his brothers to create a CBD-rich marijuana strain specifically for Charlotte.
Once Charlotte began taking the CBD oil—which the Stanley brothers named Charlotte's Web— she began to show immediate improvement, and over time it would eliminate her need for the powerful anti-epileptic medication on which she was previously reliant.
Eventually, Charlotte was able to walk, play and even feed herself again. And with the help of a documentary by CNN's Dr Sanjay Gupta, she would act as symbol of the incredible benefits that medicinal cannabis can provide for patients who have exhausted all other conventional treatment methods.
In fact, the documentary proved so influential that Colorado was soon flooded with an influx of "marijuana refugees"—which were primarily families with children who suffered from Dravet syndrome or other similar conditions—seeking to move to the state due to its liberal medicinal cannabis laws.
As time went on, Charlotte would also become an increasingly prominent figure in the movement to legalize medicinal cannabis throughout the US.
As a result of her family's efforts, there are now 47 US states that permit CBD product in some form, while Charlotte's Web (CSE:CWEB) has become one of the best-selling cannabis products available on the market.
"She was a light that lit the world. She was a little girl who carried us all on her small shoulders," the Stanley Brothers wrote in an official statement.
"What began as her story, became the shared story of hundreds of thousands, and the inspiration of many millions more in the journey of their betterment."
"Charlotte was and will be, the heartbeat of our passion, and the conviction that the dignity and health of a human being is their right."
This pot stock could reach new heights in 2020 due to Coronavirus
The COVID-19 pandemic is showing no signs of slowing down, and as global markets enter meltdown many cannabis companies are feeling the effects of capital crunch.
While the market crash will continue for some time, it represents a golden opportunity for investors who are capable of riding out the volatility until share prices rally.
Luckily, one pot stock has developed antimicrobial drug that can already treat two superbugs while limiting their ability to develop antibiotic resistance.
Investors can also start picking up shares at rock bottom prices, as global investor sentiment continues to dampen thanks to COVID-19.
& Keep Up to Date
Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!